How do you adjust levothyroxine (T4) medication for hypothyroidism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adjusting Levothyroxine for Hypothyroidism

Adjust levothyroxine dose by 12.5-25 mcg increments based on TSH levels, recheck TSH in 6-8 weeks after each adjustment, and target a TSH within the reference range (0.5-4.5 mIU/L) for most patients. 1

Initial Dosing Strategy

Starting dose depends critically on age and cardiac status:

  • For patients <70 years without cardiac disease: Start with full replacement dose of approximately 1.6 mcg/kg/day 1, 2
  • For patients >70 years or with cardiac disease/multiple comorbidities: Start with 25-50 mcg/day and titrate gradually 1, 2

Dose Adjustment Algorithm

When TSH is elevated (inadequate treatment):

  • Use 12.5-25 mcg increments based on current dose and patient characteristics 1
  • For younger patients (<70 years) without cardiac disease, use 25 mcg increments 1
  • For elderly patients (>70 years) or those with cardiac disease, use smaller 12.5 mcg increments to avoid cardiac complications 1
  • Larger adjustments risk overtreatment and should be avoided 1

When TSH is suppressed (overtreatment):

  • For TSH <0.1 mIU/L: Decrease dose by 25-50 mcg 1
  • For TSH 0.1-0.4 mIU/L: Decrease dose by 12.5-25 mcg 1
  • First confirm the indication for therapy—patients with thyroid cancer may require intentional TSH suppression 1

Monitoring Protocol

Critical timing for TSH rechecking:

  • Recheck TSH every 6-8 weeks after any dose adjustment until target is achieved 1, 2, 3
  • Wait the full 6-8 weeks before making further adjustments—adjusting too frequently before reaching steady state is a common pitfall 1
  • Once stable on appropriate dose, monitor TSH every 6-12 months 1, 2
  • Free T4 can help interpret persistent abnormal TSH levels, as TSH may take longer to normalize 1, 2

Exception for high-risk patients: Those with atrial fibrillation, cardiac disease, or serious medical conditions may warrant more frequent monitoring—consider repeating within 2 weeks 1

Target TSH Levels

For primary hypothyroidism: Target TSH 0.5-4.5 mIU/L (within reference range) 1

Special populations requiring different targets:

  • Pregnant women: Maintain TSH in trimester-specific reference range; increase dose by 12.5-25 mcg per day as needed, monitoring TSH every 4 weeks 3
  • Thyroid cancer patients (intermediate/high-risk): Target TSH 0.1-0.5 mIU/L for mild suppression 1
  • Thyroid cancer patients (structural incomplete response): Target TSH <0.1 mIU/L for aggressive suppression 1

Treatment Thresholds Based on TSH Level

TSH >10 mIU/L: Initiate or increase levothyroxine regardless of symptoms—this level carries approximately 5% annual risk of progression to overt hypothyroidism 1, 2

TSH 4.5-10 mIU/L: Monitor every 4-6 weeks without treatment if asymptomatic; consider treatment trial if symptomatic 1, 2

TSH <0.1 mIU/L on therapy: Reduce dose immediately to prevent complications of iatrogenic hyperthyroidism 1

Common Pitfalls to Avoid

Adjusting doses too frequently: Always wait 6-8 weeks between adjustments to allow levothyroxine to reach steady state 1, 3

Excessive dose increases: Approximately 25% of patients on levothyroxine are unintentionally maintained on doses sufficient to fully suppress TSH, increasing risks for osteoporosis, fractures, and atrial fibrillation 1

Ignoring medication interactions: Iron and calcium reduce levothyroxine absorption; enzyme inducers reduce efficacy 4

Failing to distinguish treatment indications: Patients with thyroid cancer requiring TSH suppression need different targets than those with primary hypothyroidism 1

Risks of Improper Dosing

Undertreatment consequences:

  • Persistent hypothyroid symptoms 1
  • Adverse cardiovascular effects 1
  • Abnormal lipid metabolism 1
  • Reduced quality of life 1

Overtreatment consequences:

  • Atrial fibrillation and cardiac arrhythmias, especially in elderly 1, 2
  • Osteoporosis and increased fracture risk 1, 2
  • Left ventricular hypertrophy 1
  • Bone demineralization in postmenopausal women 1

Pregnancy Considerations

Pre-existing hypothyroidism: Increase levothyroxine dose by 12.5-25 mcg per day when pregnancy confirmed; monitor TSH every 4 weeks during pregnancy 3

Post-delivery: Reduce to pre-pregnancy dose immediately after delivery and recheck TSH 4-8 weeks postpartum 3

References

Guideline

Initial Treatment for Elevated TSH

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Hypothyroidism with Levothyroxine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.